Pharma

Your Article Summary

See Latest Articles

New Large-Scale, Global Study Provides Additional Information About an Intensified Dose-Regimen of Plavix in Acute Coronary Syndrome Patients Undergoing Angioplasty
Bristol Myers-Squibb Company, 09/16/09

The OASIS study group will present initial results of the CURRENT–OASIS 7 clinical trial at the European Society of Cardiology congress in Barcelona. Sanofi–aventis and Bristol–Myers Squibb Company, co–commercialization and co–development partners for PLAVIX, were sponsors of the study.

Today in Drug Trials...keeping you current

Receive free subspecialty "5-minute updates" via email

ARIAD Announces Full Enrollment in Phase 3 Succeed Trial Evaluating Ridaforolimus in Patients with Metastatic Sarcomas
ARIAD Pharmaceuticals, 12/18/09

Phase I trial of motexafin gadolinium and doxorubicin in the treatment of advanced malignancies
Investigational New Drugs, 12/18/09

Prognostic Factors in Idiopathic Pulmonary Fibrosis
The American Journal of the Medical Sciences, 12/17/09

 See all of Drug Trials